BIOWOUND SOLUTIONS ACQUIRES EXCLUSIVE LICENSE TO SELL AND MARKET BIO-CONNEKT FROM MLM BIOLOGICS

BioWound Solutions has announced that it has acquired the exclusive sales and marketing rights to MLM Biologic’s bio-Connekt® Wound Matrix in the United States and its territories. ​

The bio-ConneKt® Wound Matrix is a collagen-based wound dressing for the local management of moderately to heavily exuding wounds. The product has an FDA 510(k) clearance and is indicated for use wherever there is breach of the skin. Some of the common types of wounds where bio-ConneKt® Wound Matrix has been used include: full and partial thickness wounds, draining wounds, tunneling wounds, pressure sores/ulcers, venous ulcers, chronic vascular ulcers, diabetic ulcers, trauma wounds (e.g. abrasions, lacerations, partial thickness burns, skin tears), and surgical wounds (e.g. donor sites/grafts, post-laser surgery, post-Mohs’ surgery, podiatric wounds, dehisced surgical incisions).

Nick Andolino, Managing Partner of BioWound Solutions commented, “We are extremely excited to partner with MLM Biologics for the sales and marketing of bio-Connekt Wound Matrix. ​ MLM has done an outstanding job developing the product and achieving great clinical results over the past few years. ​ We believe that bio-Connekt will be a critical part of our portfolio and we look forward to the future."

“The strengths of MLM Biologics are our product development and manufacturing capabilities” stated Dr. Chandra Nataraj, CEO of MLM Biologics. ​ He continued, “By partnering with BioWound Solutions, experts in the commercialization of wound care products, we feel that bio-Connekt will be made available to many more patients than we could have done alone, and we can internally focus on developing many more innovative and market-changing products.” ​

ABOUT BIOWOUND SOLUTIONS:

BioWound Solutions is company focused on the wound care space, providing healthcare practitioners with a myriad of solutions designed to achieve healing and avoid complications such as amputations and infections.

ABOUT MLM BIOLOGICS:

At MLM Biologics, we focus on wound closure and not just wound management. We achieve this by delivering optimum wound care solutions for patients and providers. ​ With help and collaboration of other forward-thinking medical and research professionals, MLM Biologics is has established its presence in various places around the globe, and is generating next generation products based on our proprietary technologies.